Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Individuals with congenital or acquired prolongation of the QT interval, or long QT syndrome (LQTS), are at risk of life-threatening ventricular arrhythmia. LQTS is commonly genetic in origin but can also be caused or exacerbated by environmental factors. A missense mutation in the L-type calcium channel Ca(V)1.2 leads to LQTS in patients with Timothy syndrome. To explore the effect of the Timothy syndrome mutation on the electrical activity and contraction of human cardiomyocytes, we reprogrammed human skin cells from Timothy syndrome patients to generate induced pluripotent stem cells, and differentiated these cells into cardiomyocytes. Electrophysiological recording and calcium (Ca(2+)) imaging studies of these cells revealed irregular contraction, excess Ca(2+) influx, prolonged action potentials, irregular electrical activity and abnormal calcium transients in ventricular-like cells. We found that roscovitine, a compound that increases the voltage-dependent inactivation of Ca(V)1.2 (refs 6-8), restored the electrical and Ca(2+) signalling properties of cardiomyocytes from Timothy syndrome patients. This study provides new opportunities for studying the molecular and cellular mechanisms of cardiac arrhythmias in humans, and provides a robust assay for developing new drugs to treat these diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Earlier studies in cardiomyocytes12 from TS individuals indicated that roscovitine2,3,29, a cyclin-dependent kinase blocker that also increases L-type channel inactivation, can reduce the prolongation of the cardiac AP in cells from TS individuals.”
From Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome (2011) · cites this paper as [12]
In the citing paper
“Some of the hiPS cell lines used in this study were extensively characterized previously23,61 using immunostaining with anti–NANOG and TRA 2–49/6E antibodies, karyotyping, generation of teratoma in nude mice and mapping of viral integration sites (Extended Data Fig. 1a).”
From Neuronal defects in a human cellular model of 22q11.2 deletion syndrome (2020) · cites this paper as [61]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · cited 1×
“We next reprogrammed the fibroblasts to generate iPSCs using four retroviruses containing SOX2, OCT3/4, KLF4 and C-MYC 20 , 21 .”
CaV1.2 Calcium Channel Dysfunction Causes a Multisystem Disorder Including Arrhythmia and Autism
Splawski, I., Timothy, K. W., Sharpe, L. M., Decher, N., Kumar, P., Bloise, R., Napolitano, C., Schwartz, P. J., Joseph, R. M., Condouris, K., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.011 · Cited by 1,586
Sudden Death Due to Cardiac Arrhythmias
Huikuri, H. V., Castellanos, A., & Myerburg, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmra000650 · Cited by 1,466
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Meijer, L., Borgne, A., Mulner, O., Chong, J. P. J., Blow, J. J., Inagaki, N., Inagaki, M., Delcros, J., & Moulinoux, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-2-00527.x · Cited by 1,352
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251
Generation of Pluripotent Stem Cells from Adult Mouse Liver and Stomach Cells
Aoi, T., Yae, K., Nakagawa, M., Ichisaka, T., Okita, K., Takahashi, K., Chiba, T., & Yamanaka, S. (2008) · Science · doi:10.1126/science.1154884 · Cited by 1,058
He, J.-Q., Ma, Y., Lee, Y., Thomson, J. A., & Kamp, T. J. (2003) · Circulation Research · doi:10.1161/01.res.0000080317.92718.99 · Cited by 800
Schwartz, P. J. (1997) · Current Problems in Cardiology · doi:10.1016/s0146-2806(97)80009-6 · Cited by 693
Cited by
Items 101–200 of 720
Jang, J., Yoo, J.-E., Lee, J., Lee, D. R., Kim, J. Y., Huh, Y. J., Kim, D., Park, C., Hwang, D., Kim, H.-S., et al. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.3.015 · Cited by 120
Modeling psychiatric disorders at the cellular and network levels
Brennand, K. J., Simone, A., Tran, N., & Gage, F. H. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.20 · Cited by 119
Induced Pluripotent Stem Cell–Derived Cardiomyocytes: Boutique Science or Valuable Arrhythmia Model?
Knollmann, B. C. (2013) · Circulation Research · doi:10.1161/circresaha.112.300567 · Cited by 118
Magdy, T., Schuldt, A. J. T., Wu, J. C., Bernstein, D., & Burridge, P. W. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-053110 · Cited by 109
Physiologically inspired cardiac scaffolds for tailored in vivo function and heart regeneration
Kaiser, N. J., & Coulombe, K. L. K. (2015) · Biomedical Materials · doi:10.1088/1748-6041/10/3/034003 · Cited by 107
Boczek, N. J., Ye, D., Jin, F., Tester, D. J., Kelcher, A. M. H., Bos, J. M., Johnson, A. J., Kanter, R. J., & Ackerman, M. J. (2015) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.115.002745 · Cited by 107
Calcium Handling Defects and Cardiac Arrhythmia Syndromes
Kistamás, K., Veress, R., Horváth, B., Bányász, T., Nánási, P. P., & Eisner, D. A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00072 · Cited by 107
Xu, S., Liu, M., Bai, Y., & Liu, H. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202009682 · Cited by 106
Matsa, E., Ahrens, J. H., & Wu, J. C. (2016) · Physiological Reviews · doi:10.1152/physrev.00036.2015 · Cited by 105
FGF12 is a candidate Brugada syndrome locus
Hennessey, J. A., Marcou, C. A., Wang, C., Wei, E. Q., Wang, C., Tester, D. J., Torchio, M., Dagradi, F., Crotti, L., Schwartz, P. J., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.09.064 · Cited by 105
Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies
Brandão, K. O., Tabel, V. A., Atsma, D. E., Mummery, C. L., & Davis, R. P. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.030320 · Cited by 104
Magdy, T., Jouni, M., Kuo, H., Weddle, C. J., Lyra‐Leite, D. M., Fonoudi, H., Romero‐Tejeda, M., Gharib, M., Javed, H., Fajardo, G., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.055801 · Cited by 104
Novel Timothy syndrome mutation leading to increase in CACNA1C window current
Boczek, N. J., Miller, E. M., Ye, D., Nesterenko, V. V., Tester, D. J., Antzelevitch, C. N., Czosek, R. J., Ackerman, M. J., & Ware, S. M. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.09.051 · Cited by 104
Fiedler, L. R., Chapman, K., Xie, M., Maifoshie, E., Jenkins, M., Golforoush, P. A., Bellahcene, M., Noseda, M., Faust, D., Jarvis, A., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.01.013 · Cited by 102
Horváth, A., Lemoine, M. D., Löser, A., Mannhardt, I., Flenner, F., Uzun, A. U., Neuber, C., Breckwoldt, K., Hansen, A., Girdauskas, E., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.01.012 · Cited by 101
Induced pluripotent stem cell-derived cardiomyocytes for drug development and toxicity testing
Sinnecker, D., Laugwitz, K., & Moretti, A. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.03.004 · Cited by 100
Current status of drug screening and disease modelling in human pluripotent stem cells
Rajamohan, D., Matsa, E., Kalra, S., Crutchley, J., Patel, A., George, V., & Denning, C. (2013) · BioEssays · doi:10.1002/bies.201200053 · Cited by 99
Clinical and Genetic Determinants of Torsade de Pointes Risk
Sauer, A. J., & Newton‐Cheh, C. (2012) · Circulation · doi:10.1161/circulationaha.111.080887 · Cited by 98
Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes
Eschenhagen, T., Mummery, C., & Knollmann, B. C. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv017 · Cited by 97
Towards chamber specific heart-on-a-chip for drug testing applications
Zhao, Y., Rafatian, N., Wang, E. Y., Wu, Q., Lai, B. F. L., Lu, R. X., Savoji, H., & Radisic, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.12.002 · Cited by 97
Ma, D., Wei, H., Lu, J., Huang, D., Liu, Z., Loh, L. J., Islam, O., Liew, R., Shim, W., & Cook, S. A. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0027-z · Cited by 96
Yamamoto, Y., Makiyama, T., Harita, T., Sasaki, K., Wuriyanghai, Y., Hayano, M., Nishiuchi, S., Kohjitani, H., Hirose, S., Chen, J., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx073 · Cited by 95
Song, B., Sun, G., Herszfeld, D., Sylvain, A., Campanale, N. V., Hirst, C. E., Caine, S., Parkington, H. C., Tonta, M. A., Coleman, H. A., et al. (2012) · Stem Cell Research · doi:10.1016/j.scr.2011.12.001 · Cited by 94
Oikonomopoulos, A., Kitani, T., & Wu, J. C. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.02.026 · Cited by 94
Therapeutic Translation of iPSCs for Treating Neurological Disease
Yu, D. X., Marchetto, M. C., & Gage, F. H. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.05.018 · Cited by 93
Gao, Y., Xue, X., Hu, D., Liu, W., Yuan, Y. Y., Hongmei, S., Li, L., Timothy, K. W., Zhang, L., Li, C., et al. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000092 · Cited by 93
Pluripotent Stem Cell Models of Human Heart Disease
Moretti, A., Laugwitz, K.-L., Dorn, T., Sinnecker, D., & Mummery, C. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014027 · Cited by 91
Validating the pharmacogenomics of chemotherapy-induced cardiotoxicity: What is missing?
Magdy, T., Burmeister, B. T., & Burridge, P. W. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.09.009 · Cited by 89
Parrotta, E. I., Lucchino, V., Scaramuzzino, L., Scalise, S., & Cuda, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124354 · Cited by 88
Kerscher, P., Turnbull, I. C., Hodge, A. J., Kim, J., Seliktar, D., Easley, C. J., Costa, K. D., & Lipke, E. A. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.12.011 · Cited by 88
Zhao, Z., Lan, H., El‐Battrawy, I., Li, X., Buljubasic, F., Sattler, K., Yücel, G., Lang, S., Tiburcy, M., Zimmermann, W., et al. (2018) · Stem Cells International · doi:10.1155/2018/6067096 · Cited by 87
Mutations in voltage-gated L-type calcium channel: implications in cardiac arrhythmia
Zhang, Q., Chen, J., Qin, Y., Wang, J., & Zhou, L. (2018) · Channels · doi:10.1080/19336950.2018.1499368 · Cited by 87
Ye, L., Muench, M. O., Fusaki, N., Beyer, A. I., Wang, J., Qi, Z., Yu, J., & Kan, Y. W. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0006 · Cited by 85
Casini, S., Verkerk, A. O., & Remme, C. A. (2017) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-017-6735-0 · Cited by 83
Human Engineered Heart Tissue Models for Disease Modeling and Drug Discovery
Tani, H., & Tohyama, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.855763 · Cited by 83
Kadota, S., Minami, I., Morone, N., Heuser, J. E., Agladze, K., & Nakatsuji, N. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs418 · Cited by 82
Human iPSC modeling of heart disease for drug development
Hnatiuk, A. P., Briganti, F., Staudt, D., & Mercola, M. A. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.02.016 · Cited by 82
Concise Review: Drug Discovery in the Age of the Induced Pluripotent Stem Cell
Ko, H. C., & Gelb, B. D. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0162 · Cited by 80
Optical mapping of optogenetically shaped cardiac action potentials
Park, S. A., Lee, S.-R., Tung, L., & Yue, D. T. (2014) · Scientific Reports · doi:10.1038/srep06125 · Cited by 80
Kinnear, C., Chang, W. Y., Khattak, S., Hinek, A., Thompson, T., Rodrigues, D. C., Kennedy, K., Mahmut, N., Pasceri, P., Stanford, W. L., et al. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0054 · Cited by 79
Huang, H., Pugsley, M. K., Fermini, B., Curtis, M. J., Koerner, J. E., Accardi, M. V., & Authier, S. (2017) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2017.04.002 · Cited by 78
Baldassarre, A. D., Cimetta, E., Bollini, S., Gaggi, G., & Ghinassi, B. (2018) · Cells · doi:10.3390/cells7060048 · Cited by 78
Sharma, A., Wu, J. C., & Wu, S. M. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt380 · Cited by 76
Human pluripotent stem cells for disease modelling and drug screening
Maury, Y., Gauthier, M., Peschanski, M., & Martinat, C. (2011) · BioEssays · doi:10.1002/bies.201100071 · Cited by 76
Parkinson's disease proteins: Novel mitochondrial targets for cardioprotection
Mukherjee, U., Ong, S., Ong, S., & Hausenloy, D. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.10.005 · Cited by 76
Devalla, H. D., & Passier, R. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aah5457 · Cited by 75
Cordeiro, J. M., Nesterenko, V. V., Sicouri, S., Goodrow, R. J., Treat, J. A., Desai, M., Wu, Y., Doss, M. X., Antzelevitch, C. N., & Diego, J. M. D. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.03.014 · Cited by 75
Recent advances in the applications of iPSC technology
Wiegand, C., & Banerjee, I. (2019) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2019.05.011 · Cited by 75
Ebert, A., Joshi, A. U., Andorf, S., Dai, Y., Sampathkumar, S., Chen, H., Li, Y., Garg, P., Toischer, K., Hasenfuss, G. P., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.313973 · Cited by 75
Neural Lineage Differentiation From Pluripotent Stem Cells to Mimic Human Brain Tissues
Hong, Y. J., & Do, J. T. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00400 · Cited by 75
Sallam, K., Li, Y., Sager, P. T., Houser, S. R., & Wu, J. C. (2015) · Circulation Research · doi:10.1161/circresaha.116.304494 · Cited by 74
Jung, G., Fajardo, G., Ribeiro, A. J. S., Kooiker, K. B., Coronado, M. J., Zhao, M., Hu, D., Reddy, S., Kodo, K., Sriram, K., et al. (2015) · The FASEB Journal · doi:10.1096/fj.15-280982 · Cited by 73
Derivation of Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling
Narsinh, K., Narsinh, K. H., & Wu, J. C. (2011) · Circulation Research · doi:10.1161/circresaha.111.240374 · Cited by 73
iPSC technology-Powerful hand for disease modeling and therapeutic screen
Kim, C. (2015) · BMB Reports · doi:10.5483/bmbrep.2015.48.5.100 · Cited by 70
Lin, Z. C., McGuire, A. F., Burridge, P. W., Matsa, E., Lou, H.-Y., Wu, J. C., & Cui, B. (2017) · Microsystems & Nanoengineering · doi:10.1038/micronano.2016.80 · Cited by 70
Mechanotransduction: Tuning Stem Cells Fate
D’Angelo, F., Tiribuzi, R., Armentano, I., Kenny, J. M., Martino, S., & Orlacchio, A. (2011) · Journal of Functional Biomaterials · doi:10.3390/jfb2020067 · Cited by 70
Calcium Channel Mutations in Cardiac Arrhythmia Syndromes
Betzenhauser, M. J., Pitt, G. S., & Antzelevitch, C. N. (2015) · Current Molecular Pharmacology · doi:10.2174/1874467208666150518114857 · Cited by 70
Paci, M., Hyttinen, J., Rodríguez, B., & Severi, S. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13282 · Cited by 70
Yamagishi, H., Srivastava, D., Keller, B. B., Hs, B., Markwald, R. R., & Nakanishi, T. (2016) · Springer eBooks · doi:10.1007/978-4-431-54628-3 · Cited by 69
Nguemo, F., Šarić, T., Pfannkuche, K., Watzele, M., Reppel, M., & Hescheler, J. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000188069 · Cited by 69
Human Tissue-Engineered Model of Myocardial Ischemia–Reperfusion Injury
Chen, T. F., & Vunjak‐Novakovic, G. (2019) · Tissue Engineering Part A · doi:10.1089/ten.tea.2018.0212 · Cited by 67
Ion Channel Drug Discovery: Challenges And Future Directions
Wickenden, A., Priest, B. T., & Erdemli, G. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.4 · Cited by 67
Motta, B. M., Pramstaller, P. P., Hicks, A. A., & Rossini, A. (2017) · Stem Cells International · doi:10.1155/2017/8960236 · Cited by 67
Fuerstenau-Sharp, M., Zimmermann, M. E., Stark, K. J., Jentsch, N., Klingenstein, M., Drzymalski, M. A., Wagner, S., Maier, L. S., Hehr, U., Baessler, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126596 · Cited by 67
Human Pluripotent Stem Cell-Derived Cardiomyocytes as Research and Therapeutic Tools
Acimovic, I., Vilotic, A., Pesl, M., Lacampagne, A., Dvorak, P., Rotrekl, V., & Meli, A. C. (2014) · BioMed Research International · doi:10.1155/2014/512831 · Cited by 66
Blazeski, A., Zhu, R., Hunter, D. W., Weinberg, S. H., Zambidis, E. T., & Tung, L. (2012) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2012.07.013 · Cited by 66
Hamasaki, M., Hashizume, Y., Yamada, Y., Katayama, T., Hohjoh, H., Fusaki, N., Nakashima, Y., Furuya, H., Haga, N., Takami, Y., et al. (2012) · Stem Cells · doi:10.1002/stem.1221 · Cited by 66
van Mil, A., Balk, G. M., Neef, K., Buikema, J. W., Asselbergs, F. W., Wu, S. M., Doevendans, P. A., & Sluijter, J. P. G. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy208 · Cited by 65
Induced pluripotent stem cell–derived cardiomyocytes in studies of inherited arrhythmias
Priori, S. G., Napolitano, C., Di Pasquale, E., & Condorelli, G. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62838 · Cited by 65
Generating Human Neurons In Vitro and Using Them to Understand Neuropsychiatric Disease
Paşca, S. P., Panagiotakos, G., & Dolmetsch, R. E. (2014) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062012-170328 · Cited by 64
Self-citationClinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine
Oh, Y., Wei, H., Ma, D., Sun, X., & Liew, R. (2012) · Heart · doi:10.1136/heartjnl-2011-301317 · Cited by 64
Harnessing organs-on-a-chip to model tissue regeneration
Tavakol, D. N., Fleischer, S., & Vunjak-Novakovic, G. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.05.008 · Cited by 63
The case for induced pluripotent stem cell‐derived cardiomyocytes in pharmacological screening
Khan, J. M., Lyon, A. R., & Harding, S. E. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02118.x · Cited by 63
Wen, J.-Y., Wei, C., Shah, K., Wong, J., Wang, C., & Chen, H.-S. V. (2015) · Circulation Journal · doi:10.1253/circj.cj-15-0363 · Cited by 63
The Role of Tissue Engineering and Biomaterials in Cardiac Regenerative Medicine
Zhao, Y., Feric, N. T., Thavandiran, N., Nunes, S. S., & Radisic, M. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.08.027 · Cited by 63
Rajamohan, D., Kalra, S., Hoang, M. D., George, V. T., Staniforth, A., Russell, H., Yang, X., & Denning, C. N. (2016) · Stem Cells and Development · doi:10.1089/scd.2015.0253 · Cited by 63
Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling
Iglesias‐García, O., Pelacho, B., & Prósper, F. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.04.022 · Cited by 62
Laurila, E. M., Ahola, A., Hyttinen, J., & Aalto‐Setälä, K. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.12.013 · Cited by 62
Human ether-à-go-go-related potassium channel: exploring SAR to improve drug design
Cavalluzzi, M. M., Imbrici, P., Gualdani, R., Stefanachi, A., Mangiatordi, G. F., Lentini, G., & Nicolotti, O. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.11.005 · Cited by 62
Modeling Timothy Syndrome with iPS Cells
Yazawa, M., & Dolmetsch, R. E. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9444-x · Cited by 61
Self-citationCACNA1C-Related Channelopathies
Herold, K., Hussey, J. W., & Dick, I. E. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2022_624 · Cited by 61
The Potential of Stem Cells for the Restoration of Auditory Function in Humans
Hu, Z., & Ulfendahl, M. (2013) · Regenerative Medicine · doi:10.2217/rme.13.32 · Cited by 61
Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes
Giacomelli, E., Mummery, C. L., & Bellin, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2546-5 · Cited by 60
Mahida, S., Hogarth, A. J., Cowan, C., Tayebjee, M. H., Graham, L., & Pepper, C. (2013) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-013-9779-5 · Cited by 60
Bhagwan, J. R., Collins, E. M., Mosqueira, D., Bakar, M., Johnson, B. B., Thompson, A., Smith, J. G. W., & Denning, C. N. (2019) · F1000Research · doi:10.12688/f1000research.19894.2 · Cited by 60
Martins, A. M., Vunjak-Novakovic, G., & Reis, R. L. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-013-9487-7 · Cited by 59
Dai, Y., Amenov, A., Ignatyeva, N., Koschinski, A., Xu, H., Soong, P. L., Tiburcy, M., Linke, W. A., Zaccolo, M., Hasenfuss, G. P., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-56597-3 · Cited by 58
Advances in cardiac tissue engineering and heart‐on‐a‐chip
Kieda, J., Shakeri, A., Landau, S., Wang, E. Y., Zhao, Y., Lai, B. F., Okhovatian, S., Wang, Y., Jiang, R., & Radisic, M. (2023) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37633 · Cited by 56
Pourrier, M., & Fedida, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020657 · Cited by 56
Human disease modeling with induced pluripotent stem cells
Trounson, A. O., Shepard, K. A., & DeWitt, N. D. (2012) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2012.07.004 · Cited by 56
Embryonic type Na+ channel β-subunit, SCN3B masks the disease phenotype of Brugada syndrome
Okata, S., Yuasa, S., Suzuki, T., Ito, S., Makita, N., Yoshida, T., Li, M., Kurokawa, J., Seki, T., Egashira, T., et al. (2016) · Scientific Reports · doi:10.1038/srep34198 · Cited by 56
Stem Cell-Derived Systems in Toxicology Assessment
Suter-Dick, L., Alves, P. M., Blaauboer, B. J., Bremm, K.-D., Brito, C., Coecke, S., Flick, B., Fowler, P., Hescheler, J., Ingelman-Sundberg, M., et al. (2015) · Stem Cells and Development · doi:10.1089/scd.2014.0540 · Cited by 56
Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Versatile Tool for Arrhythmia Research
Sinnecker, D., Goedel, A., Laugwitz, K., & Moretti, A. (2013) · Circulation Research · doi:10.1161/circresaha.112.268623 · Cited by 56
Sala, L., Oostwaard, D. W., Tertoolen, L. G. J., Mummery, C. L., & Bellin, M. (2017) · Journal of Visualized Experiments · doi:10.3791/55587 · Cited by 54
Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells
Tanaka, A., Yuasa, S., Node, K., & Fukuda, K. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160818894 · Cited by 54
Uzun, A. U., Mannhardt, I., Breckwoldt, K., Horváth, A., Johannsen, S. S., Hansen, A., Eschenhagen, T., & Christ, T. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00300 · Cited by 54
Ebert, A., Diecke, S., Chen, I. Y., & Wu, J. C. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201504395 · Cited by 54
New and TALENted Genome Engineering Toolbox
Campbell, J. M., Hartjes, K. A., Nelson, T. J., Xu, X., & Ekker, S. C. (2013) · Circulation Research · doi:10.1161/circresaha.113.301765 · Cited by 53
Concise Review: Cardiac Disease Modeling Using Induced Pluripotent Stem Cells
Yang, C., Al-Aama, J. Y., Stojković, M., Keavney, B. D., Trafford, A. W., Lako, M., & Armstrong, L. (2015) · Stem Cells · doi:10.1002/stem.2070 · Cited by 53
Genetics of ion-channel disorders
Cerrone, M., Napolitano, C., & Priori, S. G. (2012) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328352429d · Cited by 52
Metadata
- Authors
- Yazawa, M., Hsueh, B., Jia, X., Pasca, A. M., Bernstein, J. A., Hallmayer, J., & Dolmetsch, R. E.
- Affiliations
- Stanford Medicine (US)
- Baylor College of Medicine (US)
- Corresponding author
- Dolmetsch, Ricardo E.
- ORCID
- Venue
- Nature
- Published
- 2011-02-09
- Volume
- 471
- Issue
- 7337
- Pages
- 230-234
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3077925
- OpenAlex
- W2026404421
- Cited by
- 677
- References
- 29
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 21 · 2023: 17 · 2022: 31 · 2021: 35 · 2020: 31 · 2019: 35 · 2018: 34 · 2017: 48 · 2016: 56 · 2015: 72 · 2014: 54 · 2013: 88 · 2012: 84
- FWCI
- 59.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Simons Foundation
- American Heart Association
- National Institutes of Health (DP1OD003889)
- Japan Society for the Promotion of Science
- National Institute of Mental Health (R21MH087898, DP1MH099904)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- Timothy syndrome, induced pluripotent stem cells, cardiomyocytes, cardiac arrhythmias, CACNA1C, Cav1.2 L-type calcium channel, roscovitine, long QT syndrome, calcium signaling, electrophysiology, fibroblast reprogramming, drug screening
- MeSH terms
- Roscovitine, Action Potentials, Autistic Disorder, Drug Evaluation, Preclinical, Fibroblasts, Humans, Long QT Syndrome, Phenotype, Purines, Syndactyly, Patch-Clamp Techniques, Calcium Signaling, Mutation, Missense, Calcium Channels, L-Type, Myocytes, Cardiac, Cell Transdifferentiation, Induced Pluripotent Stem Cells, HEK293 Cells, Single-Cell Analysis, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.